Lung Cancer Screening:
Who, What, Where, When, and Why

Learning Objectives

1. Describe lung cancer, its causes, screening techniques and related eligibility criteria
2. Communicate the essentials of insurance coverage for lung cancer screening
3. Access lung cancer support resources and lung cancer screening information
4. Discuss the role of smoking cessation in lung cancer screening

The estimated time to complete this activity is 1-1/2 hours, which is equivalent to 1.50 credits.

Media Format(s)
Recorded web-based slides and audio.

Certification Dates
Begins: January 20, 2017
Expires: December 31, 2019

The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

UCSF designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.

Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 credit™. If you are a pharmacist in another state, you should check with your state board for approval of this credit.

Social Workers: This course is NOT currently qualified for CEU's.

This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

This activity has been reviewed and approved by members of the UCSF CME Governing Board in accordance with UCSF CME accreditation policies. Office of CME staff, planners, reviewers, and all others in control of content have disclosed no relevant financial relationships.

Carly Ornstein and Bill Blatt have each disclosed that neither have a financial interest/arrangement or affiliation with any commercial interests who provide products or services relating to their presentation(s) in this continuing medical education activity. 

UC Online Privacy Policy
http://meded.ucsf.edu/cme/privacy-policy

PC

• Microsoft Windows 2000 SE or above.
• Internet Explorer (v5.5 or greater), Chrome or Firefox
• Flash Player Plug-in (9.0 or later) Check your version here.
• Sound Card & Speakers
• 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
• Adobe Acrobat Reader*

MAC

• MAC OS 10.2.8
• Safari, Chrome or Firefox
• Flash Player Plug-in (9.0 or later) Check your version here.
• Sound Card & Speakers
• 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
• Adobe Acrobat Reader*
• Internet Explorer is not supported on the Macintosh.

* Required to view printable (PDF) version of the lesson.

UCSF School of Medicine
Office of Continuing Medical Education
3333 California Street, Suite 450
San Francisco, CA  94118

Phone: (415) 476-4251(415) 476-4251 • Fax: (415) 476-0318
Email: info@ocme.ucsf.edu • Web: http://cme.ucsf.edu